EMA recommends marketing authorization for donanemab (Kisunla)
This announcement reverses an earlier recommendation made by the EMA regarding donanemab as a treatment for the treatment of early symptomatic Alzheimer's disease in adults.
News
News, blogs and stories from across the field of dementia, the work of Alzheimer’s Disease International and our members.
Featured news
The 78th World Health Assembly agrees to extend the Global Action Plan on the Public Health Response to Dementia
The 78th World Health Assembly has been a whirlwind week for ADI as, after 18-months of advocacy, the World Health Assembly has agreed to extend the Global Action Plan on the Public Health Response to Dementia by 6-years, to 2031.
COVID-19 deaths disproportionately affecting people with dementia
At the beginning of World Alzheimer's Month, ADI highlights evidence that the COVID-19 pandemic is leading to extremely high death rates amongst people with dementia globally.
Dominican Republic adopts a national dementia plan
The Dominican Republic’s Ministry of Public Health announces that the country will be launching a national dementia plan.
Global Perspective Newsletter for July 2020
ADI's Global Perspective for July 2020 now available.
Germany adopts a national dementia plan
The German Government announces that a national dementia strategy has been officially adopted.
ADI and ITN Productions release new documentary ‘Hope in the Age of Dementia’
Alzheimer’s Disease International (ADI) and ITN Productions have co-produced a new documentary ‘Hope in the Age of Dementia'.
Diagnosis, treatment, care and support during COVID-19
The following piece is from our third 'From Plan to Impact' report and written by ADI's Communications and Policy Manager, Annie Bliss, the main author of the report. In this piece, she writes about the impact of the COVID-19 pandemic on diagnostic, treatment, care and support services for people living with dementia.
Governments must heed the lessons of COVID-19 and the disproportionate impact for people with dementia
A new report by ADI calls on world governments to ensure that dementia remains a priority during and after the COVID-19 pandemic.
Alzheimers New Zealand responds to COVID-19, then and now
Catherine Hall, Chief Executive of Alzheimers New Zealand, writes about how Alzheimers New Zealand has responded and adapted to COVID-19, both in the first weeks of lockdown and today.